An everyday vaccine offers a glimpse of what pre

Harnessing genomics and AI agents in drug discov

A new partnership with Skye Bioscience signals h

AI-powered longevity mirror offers a 30-second s

A new peer-reviewed analysis says blue zone long

Insilico Medicine announced a multi-year research

NADclinic, a UK-based global group specialising i

From diabetes breakthrough to longevity lightnin

Connected scale measures more than 60 biomarkers

LongGame Ventures’ Will Harborne on why JPM 20

By tuning proton transport, researchers aim for

New year weight loss plans collide with surge in

The global medical aesthetics market is expected

Longevity.

New Roots Films follows Longevity Hackers with s

2026 could redefine obesity treatment, as pills,

Short, food-based fasting activates body’s cle

Despite new White House deals and public pressur

The New England Journal of Medicine has published

Insilico Medicine, a clinical-stage biotechnology

Life Time said it will open its fifth athletic co

Mesoblast Limited announced changes to its Board

Hopeful mouse data suggest restoring the brain’s energy balance could do what decades of research have not: push Alzheimer’s into retreat. For more than a century, treatments for Alzheimer’s disease have largely focused on slowing decline, not turning it around. But a new study from University Hospitals Cleveland Medical Center is quietly challenging that assumption, offering a different way of thinking about the disease. Now, it’s seen not just as toxic buildup in the brain, but as a crisis of energy. In experiments involving mice and human brain tissue, researchers found that restoring balance to a molecule essential for cellular energy dramatically reversed Alzheimer’s-like damage [1]. The findings, published last week in Cell Reports Medicine, do not claim a cure. But they do reopen a door many thought was permanently closed. The center of the study is NAD+, a molecule found in every cell of the body. It helps cells turn nutrients into usable energy and repair everyday damage. NAD+ is especially important in organs that work nonstop, including the brain. Researchers examined two mouse models of Alzheimer’s alongside human Alzheimer’s brain tissue and found the same pattern: severe depletion of NAD+ [1]. “NAD+ naturally declines with age. When NAD+…

Global longevity therapeutics market projected t

As resolutions drive demand, regulators warn aga

New waist-focused criteria suggest more than 75%

Nephrodite’s device designed to ‘free patien

China’s speed, scale and infrastructure are ce

Mount Sinai digital twin study layers wearables,

GLP-1 drugs help with weight and heart health, b

Singapore-based company upgrades its flagship su

Insilico Medicine IPO signals that AI‑native d

Data-rich heart scans are fused with AI to spot

Consumer review highlights growing demand for si

Innovation meets economic caution as life scienc

Autophagy-enhancing drug candidate enters Phase

Epigenetic rejuvenation gears up for the clinic,

Singapore-based healthcare firm expands into ste

As skincare heads into 2026, experts say skin lo

New research suggests that DNA inherited from pr

Using real-time brainwave data, clinics claim to

Healthspan as a universal right, the need for ne

European Commission wants to speed up biotech, f

A collaborative study reports a multi-target nan

Northwestern researchers unveil the most detaile

TruDiagnostic has been recognised in Better Busin

ProHealth Longevity has spotlighted its oral BPC-

LiveForeverHealth announced the launch of a full-

Study links statin use to slower cognitive decli

Longevity-linked enzyme shown to regulate brain